Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (961-970 of 1,104) with videos related to

Pageof 111
Sort By:
Journal of Korean Medical Science|January 24, 2013
Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantationHo Sup Lee, Yang Soo Kim, Kihyun Kim, et al.
Blood|June 26, 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphomaHyera Kim, Hyehyun Jeong, Motoko Yamaguchi, et al.
Orphanet Journal of Rare Diseases|November 11, 2025
The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in KoreaSeung Min Hahn, Minseok Kim, Youna Kim, et al.
Cancer Research and Treatment|May 9, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Young Adult Patients with Chronic Myeloid Leukemia in Tyrosine Kinase Inhibitor Era: A Study of the Korean Blood and Marrow Transplantation RegistryHee Young Ju, Hyoung Soo Choi, Hyeon Jin Park, et al.
Kidney Medicine|August 6, 2024
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 TrialsBradley P Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegansJoon-Hee Lee, Sun-Hye Choi, Oh-Seung Kwon, et al.
Hemasphere|November 1, 2023
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 TrialsJean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, et al.
The Korean Journal of Internal Medicine|March 22, 2003
Adenocarcinoma of unknown primary siteSeo Young Song, Won Seog Kim, Hye Ran Lee, et al.
Bioresource Technology|March 16, 2020
Two-step system consisting of novel vertical flow and free water surface constructed wetland for effective sewage treatment and reuseX Cuong Nguyen, D Duc Nguyen, Q Ba Tran, et al.
Haematologica|June 22, 2019
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studiesMaria-Victoria Mateos, Andrew Spencer, Ajay K Nooka, et al.
Pageof 111

Showing results (961-970 of 1,104) with videos related to

Sort By:
Pageof 111
Journal of Korean Medical Science|January 24, 2013
Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantationHo Sup Lee, Yang Soo Kim, Kihyun Kim, et al.
Blood|June 26, 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphomaHyera Kim, Hyehyun Jeong, Motoko Yamaguchi, et al.
Orphanet Journal of Rare Diseases|November 11, 2025
The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in KoreaSeung Min Hahn, Minseok Kim, Youna Kim, et al.
Cancer Research and Treatment|May 9, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Young Adult Patients with Chronic Myeloid Leukemia in Tyrosine Kinase Inhibitor Era: A Study of the Korean Blood and Marrow Transplantation RegistryHee Young Ju, Hyoung Soo Choi, Hyeon Jin Park, et al.
Kidney Medicine|August 6, 2024
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 TrialsBradley P Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegansJoon-Hee Lee, Sun-Hye Choi, Oh-Seung Kwon, et al.
Hemasphere|November 1, 2023
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 TrialsJean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, et al.
The Korean Journal of Internal Medicine|March 22, 2003
Adenocarcinoma of unknown primary siteSeo Young Song, Won Seog Kim, Hye Ran Lee, et al.
Bioresource Technology|March 16, 2020
Two-step system consisting of novel vertical flow and free water surface constructed wetland for effective sewage treatment and reuseX Cuong Nguyen, D Duc Nguyen, Q Ba Tran, et al.
Haematologica|June 22, 2019
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studiesMaria-Victoria Mateos, Andrew Spencer, Ajay K Nooka, et al.
Pageof 111